EGFR and non-small cell lung carcinoma: To date, data on the mechanism and predictive role of PD‐L1 expression and immune‐cell infiltration in NSCLC with uncommon EGFR mutations are scarce, and further research is needed to inform patient stratification based on these biomarkers.